The 2017 Biopharma Industry Review and Outlook: Leadership Trumps Everything

The biopharma industry begins 2017 facing both a highly unpredictable incoming Administration and a more challenging payer-driven economic environment. In our annual Review and Outlook, we examine what is required of leaders in this environment and discuss several key talent management issues, including the ongoing shortage of board members, the need to bring greater diversity to both boardrooms and senior management, the growing importance of internal leadership development and the advantage that comes from effective restructuring, whether due to acquisition or growth